Cardiovascular prognosis in patients with preserved left ventricular ejection fraction and no significant ischemia
Authors Furuhashi T, Moroi M
Received 1 March 2017
Accepted for publication 31 May 2017
Published 20 June 2017 Volume 2017:8 Pages 41—48
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Editor who approved publication: Dr Richard Kones
Tatsuhiko Furuhashi, Masao Moroi
Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan
Background: Peripheral artery disease (PAD) and chronic kidney disease (CKD) are important cardiac risk factors, and stress myocardial perfusion imaging (MPI) is widely used as a diagnostic and predictive tool for coronary artery disease (CAD). We evaluated the usefulness of these risk factors for predicting cardiovascular events in patients with low cardiac risk assessed by stress MPI and echocardiography.
Methods: We included 558 patients with suspected or confirmed CAD, a preserved left ventricular ejection fraction ≥50% on echocardiography, and no significant ischemia on stress MPI (summed difference score <2). Follow-up was for 46 months.
Results: Cardiovascular events were observed in 37 patients (6.6%). Multivariate Cox regression analysis indicated that PAD (hazard ratio: 6.62, P<0.001), CKD (hazard ratio: 2.44, P=0.013), and history of CAD (hazard ratio: 2.67, P=0.003) were significant predictors of cardiovascular events. After 48 months’ follow-up, the event rate was significantly higher in patients with a history of CAD than in those without a history of CAD.
Conclusion: In patients with preserved left ventricular ejection fraction and no significant myocardial ischemia, baseline characteristics such as PAD, CKD, and history of CAD can predict cardiac risk.
Keywords: cardiac events, chronic kidney disease, coronary artery disease, left ventricular systolic function, peripheral artery disease, risk factors
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]